嗜酸性
表型
哮喘
医学
病理
内科学
生物
遗传学
基因
作者
David J. Jackson,Michael E. Wechsler,Daniel J. Jackson,David I. Bernstein,Stephanie Korn,Paul Pfeffer,Ruchong Chen,Junpei Saito,Gustavo de Luíz Martinez,Lucyna Dymek,Loretta Jacques,Nicholas Bird,Stein Schalkwijk,Douglas G. Smith,Peter Howarth,Ian Pavord
标识
DOI:10.1056/nejmoa2406673
摘要
Depemokimab is an ultra-long-acting biologic therapy with enhanced binding affinity for interleukin-5 that may enable effective 6-month dosing intervals.
科研通智能强力驱动
Strongly Powered by AbleSci AI